Lulinaheal Cream contains Luliconazole 1% w/w, a broad-spectrum antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits potent activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lulinaheal Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidal infections. The topical formulation allows for targeted delivery, minimizing systemic exposure and associated side effects. Clinical studies have demonstrated that Lulinaheal Cream provides rapid symptomatic relief, including reduction of itching, redness, and scaling, with a favorable safety profile. The cream should be applied once daily to the affected area after cleansing and drying the skin, typically for a duration of 2 to 4 weeks, depending on the severity and type of infection. Patients are advised to complete the full course of treatment to prevent recurrence and resistance development. Common adverse effects are mild and may include local irritation, burning sensation, or erythema. Lulinaheal Cream is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients.